By Will Feuer


Medtronic raised its full-year outlook for sales and adjusted earnings after the medical-device maker reported fiscal second quarter results that topped Wall Street analysts' expectations.

The company is now targeting fiscal-year organic revenue growth of 4.75%, up from 4.5%. Including the anticipated impact from currency fluctuations and other revenue, Medtronic said it anticipated organic growth of 2.6%.

The company also increased its fiscal-year adjusted earnings outlook to $5.13 a share to $5.19 a share, up from a prior range of $5.08 a share to $5.16 a share.

Chief Financial Officer Karen Parkhill cited the company's second-quarter performance and updated estimates for the impact of taxes and foreign currency on fiscal-year results in raising guidance.


Write to Will Feuer at Will.Feuer@wsj.com


(END) Dow Jones Newswires

11-21-23 0727ET